Login / Signup

Circulating Anti-GB3 Antibody as a Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy.

Andrea FrustaciRomina VerardoMichele MagnocavalloRossella SciallaLuigi SansoneMatteo Antonio Russo
Published in: Journal of clinical medicine (2023)
The present study suggests a potential positive role of anti-GB3 antibodies as a marker of overlapping cardiac inflammation in patients with FDCM.
Keyphrases
  • oxidative stress
  • left ventricular
  • heart failure
  • replacement therapy
  • risk assessment
  • climate change
  • smoking cessation